Share Price:

APNASPENAspen Pharmacare Hldgs943054 (0.58%)

Aspen concludes a collaboration agreement to manufacture and make available four Aspen-branded vaccines for Africa.

Durban, South AfricaΒ –Β JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company,Β is pleased to announce that one of its wholly-owned South African subsidiaries, Aspen SAΒ Operations (Pty) Limited (β€œAspen SA Operations”), has concluded a ten-year agreement (β€œthe Agreement”) withΒ Serum Institute of India Pvt Ltd (β€œthe Serum Institute”), the world’s largest vaccine producer,… Continue reading Aspen concludes a collaboration agreement to manufacture and make available four Aspen-branded vaccines for Africa.

Aspen’s response to Monkeypox being declared a Public Health Emergency of International Concern by WHO

Durban – JSE listed company Aspen Pharmacare Holdings Limited (Aspen), a global multinational specialty pharmaceutical company, is positively positioned to respond as a third party for capacity fill opportunities following the World Health Organisation’s (WHO) declaration of monkeypox being a Public Health Emergency of International Concern (PHEIC). This declaration is the first since that announced… Continue reading Aspen’s response to Monkeypox being declared a Public Health Emergency of International Concern by WHO

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: